Adverse events following international normalized ratio reversal in intracerebral hemorrhage

Show other versions (1)

Background: Prothrombin complex concentrates (PCCs) are frequently used to reverse the effect of vitamin K antagonists (VKAs) in patients with non-traumatic intra

Saved in:

Bibliographic Details
Main Authors:	Laible, Mona (Author) , Jenetzky, Ekkehart (Author) , Beynon, Christopher (Author) , Müller, Oliver J. (Author) , Sander, Peter (Author) , Schüler, Svenja (Author) , Purrucker, Jan (Author) , Möhlenbruch, Markus Alfred (Author) , Steiner, Thorsten (Author) , Veltkamp, Roland (Author) , Ringleb, Peter A. (Author) , Rizos, Timolaos (Author)
Format:	Article (Journal)
Language:	English
Published:	19 August 2016
In:	Cerebrovascular diseases Year: 2016, Volume: 42, Issue: 5/6, Pages: 446-454
ISSN:	1421-9786
DOI:	10.1159/000448815
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1159/000448815 Verlag, Volltext: http://www.karger.com/Article/FullText/448815
Author Notes:	Mona Laible, Ekkehart Jenetzky, Christopher Beynon, Oliver Josef Müller, Peter Sander, Svenja Schüler, Jan Purrucker, Markus Möhlenbruch, Thorsten Steiner, Roland Veltkamp, Peter Arthur Ringleb, Timolaos Rizos

Description
Summary:	Background: Prothrombin complex concentrates (PCCs) are frequently used to reverse the effect of vitamin K antagonists (VKAs) in patients with non-traumatic intra
Item Description:	Gesehen am 24.10.2014
Physical Description:	Online Resource
ISSN:	1421-9786
DOI:	10.1159/000448815